IHH Healthcare's outlook appears positive, given its robust expansion plan, Public Investment Bank analyst Thye May Ting says in a note. This includes its acquisition of Island Hospital, which is projected to deliver over MYR200 million in synergies over the next five years, she says. IHH's focus on organic and inorganic expansion, along with optimizing assets that are underperforming, positions the company well for future growth, she notes. Its efforts to enhance efficiency through digitization and value-based healthcare initiatives could equip IHH to navigate macroeconomic challenges, she adds. Public IB raises IHH's target price to MYR8.64 from MYR7.68, while maintaining an outperform rating on the stock. Shares are 0.1% lower at MYR7.22.(yingxian.wong@wsj.com)
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。